Glyxambi contains a combination of empagliflozin and linagliptin. Empagliflozin and linagliptin are oral diabetes medicines that help control blood sugar levels. Empagliflozin works by helping the kidneys get rid of glucose from your bloodstream. Linagliptin works by regulating the levels of insulin your body produces after eating. Glyxambi is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. Glyxambi is also used to lower the risk of death from heart attack, stroke, or heart failure in adults with type 2 diabetes who also have heart disease.

Jentadueto is a medicine that contains the active substances linagliptin and metformin hydrochloride. It is available as tablets. Jentadueto is used in adults with type 2 diabetes to improve the control of blood glucose levels. It is used in addition to diet and exercise in patients who are not satisfactorily controlled on metformin used on its own, in patients who are already taking a combination of linagliptin and metformin as separate tablets, in combination with a sulphonylurea or insulin in patients who are not satisfactorily controlled on this medicine and metformin.

Jentadueto XR are oral diabetes medicines that help control blood sugar levels. Metformin works by decreasing glucose (sugar) production in the liver and decreasing absorption of glucose by the intestines. Linagliptin works by regulating the levels of insulin your body produces after eating. Jentadueto XR is a combination medicine used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. Jentadueto XR is not for treating type 1 diabetes.

Tradjenta (linagliptin) is an oral diabetes medicine that helps control blood sugar levels. It works by regulating the levels of insulin your body produces after eating.Tradjenta is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.